Free Trial

Cwm LLC Cuts Stake in Cabot Corporation $CBT

Cabot logo with Basic Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Cwm LLC cut its stake by 93.3% in Cabot during Q4, selling 39,555 shares and leaving it with 2,835 shares worth about $188,000.
  • Cabot beat Q2 adjusted EPS ($1.61 vs. $1.47), raised the quarterly dividend 5% to $0.4725, and cited battery‑materials momentum and solid segment EBIT despite a ~3.4% year‑over‑year revenue decline.
  • Management set FY‑2026 guidance of $6.00–$6.50 EPS (midpoint roughly in line with Street), the consensus analyst rating is Hold with a $73.75 target, and the company plans manufacturing closures in South America and Europe that could trigger restructuring costs.
  • MarketBeat previews top five stocks to own in June.

Cwm LLC cut its stake in Cabot Corporation (NYSE:CBT - Free Report) by 93.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,835 shares of the specialty chemicals company's stock after selling 39,555 shares during the quarter. Cwm LLC's holdings in Cabot were worth $188,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in the stock. Farther Finance Advisors LLC grew its stake in shares of Cabot by 9.6% in the fourth quarter. Farther Finance Advisors LLC now owns 1,873 shares of the specialty chemicals company's stock worth $124,000 after acquiring an additional 164 shares during the period. Gabelli Funds LLC grew its stake in shares of Cabot by 1.3% in the third quarter. Gabelli Funds LLC now owns 13,570 shares of the specialty chemicals company's stock worth $1,032,000 after acquiring an additional 180 shares during the period. First Citizens Bank & Trust Co. grew its stake in shares of Cabot by 1.4% in the third quarter. First Citizens Bank & Trust Co. now owns 14,558 shares of the specialty chemicals company's stock worth $1,107,000 after acquiring an additional 206 shares during the period. Hantz Financial Services Inc. grew its stake in shares of Cabot by 227.5% in the third quarter. Hantz Financial Services Inc. now owns 429 shares of the specialty chemicals company's stock worth $33,000 after acquiring an additional 298 shares during the period. Finally, Smartleaf Asset Management LLC grew its stake in shares of Cabot by 598.0% in the third quarter. Smartleaf Asset Management LLC now owns 349 shares of the specialty chemicals company's stock worth $27,000 after acquiring an additional 299 shares during the period. 93.18% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on CBT. Mizuho set a $75.00 price target on shares of Cabot and gave the stock a "neutral" rating in a research note on Wednesday, February 4th. Jefferies Financial Group reiterated a "buy" rating and issued a $85.00 price target on shares of Cabot in a research note on Wednesday, February 4th. UBS Group lifted their price target on shares of Cabot from $74.00 to $81.00 and gave the stock a "neutral" rating in a research note on Thursday, February 5th. Finally, Zacks Research raised shares of Cabot from a "strong sell" rating to a "hold" rating in a report on Tuesday, January 27th. One research analyst has rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $73.75.

View Our Latest Report on Cabot

More Cabot News

Here are the key news stories impacting Cabot this week:

  • Positive Sentiment: Q2 adjusted EPS beat consensus — Cabot reported adjusted EPS of $1.61 vs. the Zacks/Street consensus of $1.47, giving the market a clear earnings beat despite tougher year‑ago comparisons. Cabot (CBT) Surpasses Q2 Earnings Estimates
  • Positive Sentiment: Dividend increased — the Board raised the quarterly dividend 5% to $0.4725 (annualized $1.89), supporting income investors and signaling confidence in cash flow. Cabot Corporation Board Increases Dividend
  • Positive Sentiment: Battery materials and segment performance — Management highlighted battery materials momentum and reported solid segment EBIT (Reinforcement Materials $93M; Performance Chemicals $59M), indicating growth exposure to EV/BESS demand. This helps offset softness in other end markets. Cabot Corporation Reports Second Quarter Fiscal Year 2026 Results
  • Neutral Sentiment: FY‑2026 guidance largely in line with Street — Cabot set EPS guidance at $6.00–$6.50 for FY‑2026 (consensus ~$6.24), leaving room for upside or downside within the range; the midpoint is essentially in line with expectations. Cabot Corporation Reports Second Quarter Fiscal Year 2026 Results
  • Negative Sentiment: Revenue and year‑over‑year EPS declined — Q2 net sales fell ~3.4% y/y and GAAP EPS (and adjusted EPS) were below last year’s levels, underscoring demand softness in parts of the portfolio that could pressure margins if trends persist. Cabot Q2 Press Release (PDF)
  • Negative Sentiment: Planned plant closures / asset optimization — Cabot disclosed intent to pursue manufacturing closures in South America and Europe (subject to consultation), a cost‑cutting move that could trigger restructuring charges, transitional costs or supply risks. Cabot Corporation Reports Second Quarter Fiscal Year 2026 Results

Cabot Price Performance

NYSE CBT opened at $78.97 on Wednesday. Cabot Corporation has a 12 month low of $58.33 and a 12 month high of $83.71. The stock has a market cap of $4.12 billion, a price-to-earnings ratio of 13.83, a PEG ratio of 10.00 and a beta of 0.78. The company's 50 day moving average is $73.67 and its two-hundred day moving average is $70.26. The company has a current ratio of 1.67, a quick ratio of 1.09 and a debt-to-equity ratio of 0.49.

Cabot (NYSE:CBT - Get Free Report) last released its earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 EPS for the quarter, topping analysts' consensus estimates of $1.47 by $0.14. Cabot had a net margin of 8.62% and a return on equity of 22.82%. The company had revenue of $904.00 million for the quarter, compared to analysts' expectations of $900.31 million. During the same quarter last year, the business earned $1.90 EPS. The firm's revenue was down 3.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. As a group, research analysts anticipate that Cabot Corporation will post 6.27 earnings per share for the current year.

Cabot Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, June 12th. Shareholders of record on Friday, May 29th will be paid a dividend of $0.4725 per share. This represents a $1.89 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date is Friday, May 29th. This is a positive change from Cabot's previous quarterly dividend of $0.45. Cabot's dividend payout ratio (DPR) is 31.52%.

About Cabot

(Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

Featured Stories

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cabot Right Now?

Before you consider Cabot, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.

While Cabot currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines